EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients

EGFR Mutation Status in Uighur Lung Adenocarcinoma Patients

Background and objective Epidermal growth factor receptor (EGFR), a transmembrane protein, is a member of the tyrosine kinase family. Gefitinib, an EGFR tyrosine-kinase inhibitors, has shown a high response rate in the treatment of lung cancer in patients with EGFR mutation. However, significant dif...

Full description

Bibliographic Details
Main Authors:	Li SHAN, Yan ZHANG, Feng ZHAO, Limou ZHENG, Guoqing ZHANG
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-02-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms Epidermal growth factor receptor Real-time polymerase chain reaction Gene mutation
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.04

Similar Items

Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma
by: Hui ZHANG, et al.
Published: (2015-11-01)

Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer
by: Fan YANG, et al.
Published: (2011-08-01)

EGFR Gene Mutation Statuses in Advanced Non-small Cell Lung Cancer Patients and Their Influence on Effect of Gefitinib
by: Wei ZHONG, et al.
Published: (2012-09-01)

Detecting EGFR mutations in patients with non-small cell lung cancer
by: Hammoudeh ZA, et al.
Published: (2018-10-01)

Detection and Analysis of EGFR and KRAS Mutations  in the Patients with Lung Squamous Cell Carcinomas
by: Hui ZHANG, et al.
Published: (2015-10-01)

Loop-Mediated Isothermal Amplification as Point-of-Care Testing for <i>EGFR</i>-Mutated Lung Adenocarcinoma
by: Yuichi Saito, et al.
Published: (2022-06-01)

Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations
by: Xin FENG, et al.
Published: (2015-12-01)

Studies and Progress of EGFR exon 20 Insertion Mutation in Non-small Cell Lung Cancer
by: Wensheng ZHOU, et al.
Published: (2020-02-01)

Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer
by: Yaoyao LIU, et al.
Published: (2023-12-01)

Research Progress of Targeted Therapy for EGFR Gene in Non-small Cell Lung Cancer
by: Hui ZHANG, et al.
Published: (2017-01-01)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
by: Seo Yun Kim, M.D., et al.
Published: (2019-01-01)

Correlation between Immune Microenvironment Features and EGFR Mutation Status  in Lung Adenocarcinoma
by: Hongyu ZHU, et al.
Published: (2023-03-01)

Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma
by: Zhe CAO, et al.
Published: (2020-02-01)

First-line Treatment with Furmonertinib Mesylate in Lung Adenocarcinoma Patient  with EGFR Exon 20 Insertion Mutantion
by: Zhengguo LI, et al.
Published: (2024-03-01)

CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma
by: Tong-xu Shen, et al.
Published: (2019-06-01)

Detection and Evaluation of EGFR Mutation Status in Serum of Patients with Advanced Non-small Cell Lung Cancer Treated with EGFR-TKIs
by: Ling MA, et al.
Published: (2013-06-01)

Detection and Its Clinical Significance of EGFR Gene Mutation and Gene Amplification in 187 Patients with Non-small Cell Lung Cancer
by: Qinghua ZHOU, et al.
Published: (2009-12-01)

Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer
by: Rong WANG, et al.
Published: (2022-03-01)

Immunohistochemical detections of EGFR status in NSCLC
by: Jie WANG, et al.
Published: (2015-04-01)

Analysis of the Efficacy of Immunotherapy on the Posterior Lines  of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer
by: Li MA, et al.
Published: (2021-05-01)

Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)
by: Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
Published: (2023-05-01)

The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer
by: Xuebing LI, et al.
Published: (2008-04-01)

Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations
by: Hongyue Qin, et al.
Published: (2022-09-01)

Deep CNN Model Using CT Radiomics Feature Mapping Recognizes EGFR Gene Mutation Status of Lung Adenocarcinoma
by: Baihua Zhang, et al.
Published: (2021-02-01)

Efficacy of Chemotherapy after EGFR-TKIs Resistance in 191 Patients with Unknow EGFR Gene Mutation in Advanced Lung Adenocarcinoma
by: Ping HE, et al.
Published: (2013-10-01)

Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma
by: Lili XU, et al.
Published: (2022-12-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Applicable Value of AMSS-PCR in Lung Cancer Gene Mutation Detection
by: Ke JIN, et al.
Published: (2018-11-01)

Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients  Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis:  A Single-center Retrospective Study
by: Wencheng YIN, et al.
Published: (2022-03-01)

Relationship between EGFR, ALK Gene Mutation and Imaging  and Pathological Features in Invasive Lung Adenocarcinoma
by: He YANG, et al.
Published: (2022-03-01)

Advances in Treatment of Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
by: Xue YANG, et al.
Published: (2022-05-01)

Comparison of EGFR and KRAS Status between Primary Non-small Cell Lung Cancer and Corresponding Metastases: A Systematic Review and meta-analysis
by: Chengbo HAN, et al.
Published: (2010-09-01)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
by: Lie Zheng, et al.
Published: (2022-07-01)

Detection of EGFR Gene Mutations in 100 Non-small Cell Lung Cancer Clinical Samples by a Real-time Polymerase Chain Reaction Method Using Amplification Refractory Mutation System Specific Primers and Taqman Fluorescence Probes
by: Jing ZHAO, et al.
Published: (2013-01-01)

Role of EGFR Mutation Status in Patients with Stage III Non-squamous Non-small Cell Lung Cancer Treated with Chemoradiotherapy
by: Fuhai LI, et al.
Published: (2011-09-01)

Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
by: Sang Hwa Lee, et al.
Published: (2015-11-01)

Preliminary study on double ⁃ dose icotinib successfully treated leptomeningeal metastasis in lung adenocarcinoma patient with EGFR gene sensitive mutation
by: LIU Mei, et al.
Published: (2021-11-01)

Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database
by: Guangsheng ZHU, et al.
Published: (2021-04-01)

CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses
by: Dongdong Mei, et al.
Published: (2018-12-01)

Nomogram based on preoperative CT imaging predicts the EGFR mutation status in lung adenocarcinoma
by: Guojin Zhang, et al.
Published: (2021-01-01)